Increased serum IL-17 does not predict future risk and impairment in asthma Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches Year: 2009
Serum levels of IL-6 in adult patients with moderate to severe asthma. Source: International Congress 2017 – Novel mechanisms in asthma Year: 2017
Leptin as a specific marker of risk factors in severe bronchial asthma Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
Serum levels of IL-8, IL-10 and TNFα in severe allergic asthma Source: Eur Respir J 2005; 26: Suppl. 49, 279s Year: 2005
Serum TNFα and IL8 as markers of systemic inflammation in severe asthma Source: Eur Respir J 2005; 26: Suppl. 49, 279s Year: 2005
Is serum cholesterol a risk factor for asthma? Source: Annual Congress 2012 - Asthma: risk factors and effect of anti-IgE Year: 2012
Elevated circulating MMP-9 is associated with increased exacerbation risk in COPD: results from SPIROMICS and COPDGene Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018
Serum Interleukin (IL)-6 levels in patients with severe asthma disease is associated with blood eosinophilia Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD Year: 2020
Serum levels of proangiogenic factors before and after the correction of severe hypoxemia in COPD patients Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008
Serum levels of vascular endothelial growth factor (VEGF) are elevated in patients with acute exacerbated COPD Source: Eur Respir J 2005; 26: Suppl. 49, 350s Year: 2005
Serum interleukin-6 levels correlate with malnutrition in patients with acute exacerbation of COPD Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease Year: 2009
Serum levels of IL-5, IL-6 and IL-8 in moderate and severe asthma clusters Source: International Congress 2018 – Biomarkers and lung function in airway disease Year: 2018
Elevated serum IL-12 and IL-18 levels in patients with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 424s Year: 2002
Serum TNF-a, IL-12 and IL-13 levels in severe bronchial asthma patients Source: Eur Respir J 2004; 24: Suppl. 48, 353s Year: 2004
Interleukin-10 polymorphisms influence the neonatal immune response and may be a risk factor for childhood allergic disease and wheeze Source: Annual Congress 2011 - Inflammation and genes in childhood asthma Year: 2011
Combinations of T-bet and HLX1 gene variants significantly increase childhood asthma risk Source: Annual Congress 2008 - Risk factors for childhood asthma and allergy Year: 2008
Factors influencing induced sputum cytokines and VEGF in a population of stable COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 550s Year: 2006
High serum granulocyte-colony stimulating factor characterises neutrophilic COPD exacerbations associated with dysbiosis Source: ERJ Open Res, 7 (3) 00836-2020; 10.1183/23120541.00836-2020 Year: 2021
Increased serum endotoxin levels as biomarker in acute exacerbations of COPD. Source: International Congress 2018 – Biomarkers of COPD Year: 2018
Increased levels of epidermal growth factor in sputum of smoking chronic bronchitis patients Source: Eur Respir J 2003; 22: Suppl. 45, 178s Year: 2003